Tumor Profiling Market Industry Forecast Reflecting Growth To $17.95 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Tumor Profiling Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The size of the tumor profiling market has experienced swift expansion in recent years. Its value is anticipated to rise from $11.18 billion in 2025 to $12.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.1%. The growth observed in prior periods is attributable to increasing cancer incidence rates, the expansion of molecular diagnostics laboratories, the rising application of targeted cancer therapies, breakthroughs in sequencing technologies, and an increase in oncology research funding.

The tumor profiling market is anticipated to experience robust expansion over the coming years, with projections indicating it will reach $17.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. Factors driving this growth during the forecast period include the rising acceptance of precision oncology, a heightened need for individualized cancer therapies, developments in bioinformatics platforms, the wider availability of companion diagnostics, and increased funding for translational cancer research. Key trends anticipated for the forecast period encompass a greater uptake of next-generation sequencing, an increase in multi-omics profiling methods, the growing incorporation of AI-powered data analysis, the broadening scope of personalized oncology applications, and an intensified focus on identifying new biomarkers.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

What Core Drivers Are Transforming The Tumor Profiling Market?

The increasing demand for personalized medicine is expected to fuel the expansion of the tumor profiling market moving forward. Personalized medicine is an approach that customizes healthcare treatments based on the unique characteristics of each patient. This rise is attributed to patients seeking more precise therapies that offer improved outcomes and fewer side effects compared to traditional treatments. Tumor profiling aids personalized medicine by identifying specific genetic mutations and biomarkers in a patient’s tumor, enabling targeted treatments and reducing adverse effects. For example, in February 2024, a report released by the Personalized Medicine Coalition, a US-based organization focused on advancing personalized medicine, showed that personalized medicines comprised more than one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. Therefore, the growing demand for personalized medicine is driving growth in the tumor profiling market.

How Does Segment Analysis Break Down The Tumor Profiling Market Structure?

The tumor profiling market covered in this report is segmented –

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

What Trends Are Influencing The Future Of The Tumor Profiling Market?

Leading companies active in the tumor microenvironment market are concentrating on developing advanced treatment methods, such as precision therapies, to improve effectiveness and tackle resistance mechanisms. Precision therapies are treatments specifically formulated to pinpoint and attack cancer cells using distinct molecular markers, largely leaving most normal cells unharmed. For example, in April 2024, Aubex Therapeutics Inc., a US-based biotechnology firm, introduced a new category of compounds designed to revolutionize cancer treatment by directly engaging the tumor microenvironment (TME). These innovative compounds are engineered to interact with the intricate network within the TME, which comprises cancer cells, immune cells, blood vessels, and stromal components. By influencing these interactions, Aubex’s strategy boosts the immune system’s capacity to fight tumors and disrupts processes that enable tumor growth and metastasis. This approach is intended to overcome resistance to standard therapies, providing a promising option for patients who have not responded to existing treatments.

Which Organizations Are Operating Within The Tumor Profiling Market?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Access The Complete Tumor Profiling Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Which Region Is The Dominant Market In The Tumor Profiling Market?

North America was the largest region in the tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Tumor Profiling Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Browse Through More Reports Similar to the Global Tumor Profiling Market 2026, By The Business Research Company

Cancer Profiling Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Biomarker Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795